StockData

Orchestra BioMed Holdings, Inc. (OBIO) stock

OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$7.46+0.49 (+7.03%)

Close on Nov 18, 2026Market cap $448.38MP/E –Yield –

Orchestra BioMed revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Orchestra BioMed's revenue for the twelve months ending Jun 30, 2026 was $31.98M, up 986.1% year over year. For fiscal 2025 it was $33.48M, up 1169.2% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$33.48M+1169.2%
FY2024Dec 31, 2024$2.64M-4.4%
FY2023Dec 31, 2023$2.76M-21.9%
FY2022Dec 31, 2022$3.53M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$88.00K-89.5%
Q1 FY2026Mar 31, 2026$110.00K-87.3%
Q4 FY2025Dec 31, 2025$30.92M+12120.2%
Q3 FY2025Sep 30, 2025$861.00K-12.8%
Q2 FY2025Jun 30, 2025$836.00K+7.5%
Q1 FY2025Mar 31, 2025$868.00K+40.0%
Q4 FY2024Dec 31, 2024$253.00K-3.4%
Q3 FY2024Sep 30, 2024$987.00K+135.6%
Q2 FY2024Jun 30, 2024$778.00K-15.0%
Q1 FY2024Mar 31, 2024$620.00K-46.7%
Q4 FY2023Dec 31, 2023$262.00K-76.2%
Q3 FY2023Sep 30, 2023$419.00K-64.0%
Q2 FY2023Jun 30, 2023$915.00K+128.2%
Q1 FY2023Mar 31, 2023$1.16M+34.4%
Q4 FY2022Dec 31, 2022$1.10M–
Q3 FY2022Sep 30, 2022$1.16M–
Q2 FY2022Jun 30, 2022$401.00K–
Q1 FY2022Mar 31, 2022$866.00K–

More Orchestra BioMed figures

See a number that looks wrong?